COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS

Patient frailty is associated with adverse health outcomes and increased risk of mortality. This ARISTOPHANES study subgroup analysis used multiple data sources to evaluate stroke/systemic embolism (S/SE) and major bleeding (MB) among frail nonvalvular atrial fibrillation (NVAF) patients prescribed